SciVision Biotech Inc (1786) — Cash Flow Quality Index
SciVision Biotech Inc (1786) has a Cash Flow Quality Index of -0.21x as of December 2025. Operating cash flow of NT$-13.02 Million is below net income of NT$63.18 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 1786 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SciVision Biotech Inc Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for SciVision Biotech Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SciVision Biotech Inc (1786) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for SciVision Biotech Inc (2011–2025)
Year-by-year earnings quality comparison for SciVision Biotech Inc. For live market cap and the full company financial profile, see how much is SciVision Biotech Inc worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | NT$123.99 Million | NT$162.34 Million | ▼ -31.4% |
| 2024 | 1.11x | NT$269.87 Million | NT$242.25 Million | ▼ -27.1% |
| 2023 | 1.53x | NT$272.01 Million | NT$177.90 Million | ▲ +48.9% |
| 2022 | 1.03x | NT$178.21 Million | NT$173.55 Million | ▲ +21.0% |
| 2021 | 0.85x | NT$98.51 Million | NT$116.06 Million | ▲ +2.3% |
| 2020 | 0.83x | NT$126.47 Million | NT$152.49 Million | ▼ -45.5% |
| 2019 | 1.52x | NT$204.40 Million | NT$134.28 Million | ▲ +26.9% |
| 2018 | 1.20x | NT$111.70 Million | NT$93.10 Million | ▲ +70.2% |
| 2017 | 0.70x | NT$15.98 Million | NT$22.67 Million | ▼ -33.8% |
| 2015 | 1.06x | NT$49.81 Million | NT$46.77 Million | ▼ -10.4% |
| 2013 | 1.19x | NT$37.27 Million | NT$31.36 Million | ▲ +44.0% |
| 2012 | 0.83x | NT$51.52 Million | NT$62.43 Million | ▲ +13.7% |
| 2011 | 0.73x | NT$37.13 Million | NT$51.16 Million | — |